← FDA Drug Approvals (Drugs@FDA)

GELNIQUE 3%

NDA · New Drug Application · Sponsor: ALLERGAN · Approved 2011-12-07

Drug application

FDA Application #

NDA202513

Application type

New Drug Application

Brand name

GELNIQUE 3%

Generic name

Oxybutynin

Active ingredients

OXYBUTYNIN

Dosage form

GEL, METERED

Route

TRANSDERMAL

Marketing status

Discontinued

Sponsor

ALLERGAN

First approval

2011-12-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown